Release of intracoronary microparticles during stent implantation into stable atherosclerotic lesions under protection with an aspiration device

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Horn, Patrick ^a   Baars, Theodor ^b   Kahlert, Philipp ^b   Heiss, Christian ^a   Westenfeld, Ralf ^a   Kelm, Malte ^a   Erbel, Raimund ^b   Heusch, Gerd ^b   Kleinbongard, Petra ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD235 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; LYMPHOCYTE ANTIGEN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE MICROPARTICLE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE MICROPARTICLE; MALE; MEMBRANE MICROPARTICLE; PLATELET MICROPARTICLE; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; STABLE ANGINA PECTORIS; ADVERSE EFFECTS; ANGINA, STABLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTRICTION, PATHOLOGIC; CORONARY ARTERY DISEASE; MIDDLE AGED; PATHOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; SUCTION;

ANGINA, STABLE; CELL-DERIVED MICROPARTICLES; CONSTRICTION, PATHOLOGIC; CORONARY ARTERY DISEASE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; SUCTION;

EID: 84928578111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124904     Document Type: Article

References (55)

1. Baars T, Kleinbongard P, Boese D, Konorza T, Moehlenkamp S, Hippler J, et al. Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential. Basic Res Cardiol. 2012; 107: 303. doi: 10.1007/s00395-012-0303-3 PMID: 23052640
2. Leineweber K, Boese D, Vogelsang M, Haude M, Erbel R, Heusch G. Intense vasoconstriction in response to aspirate from stented saphenous vein aortocoronary bypass grafts. J Am Coll Cardiol. 2006; 47: 981-986. PMID: 16516081
3. Kleinbongard P, Baars T, Mohlenkamp S, Kahlert P, Erbel R, Heusch G. Aspirate from human stented native coronary arteries vs. saphenous vein grafts: more endothelin but less particulate debris. Am J Physiol Heart Circ Physiol. 2013; 305: H1222-H1229. doi: 10.1152/ajpheart.00358.2013 PMID: 23934849
4. Kleinbongard P, Boese D, Baars T, Moehlenkamp S, Konorza T, Schoener S, et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res. 2011; 108: 344-352. doi: 10.1161/CIRCRESAHA.110.235713 PMID: 21183739
5. Heusch G, Kleinbongard P, Boese D, Levkau B, Haude M, Schulz R, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009; 120: 1822-1836. doi: 10.1161/CIRCULATIONAHA.109.888784 PMID: 19884481
6. Kleinbongard P, Konorza T, Boese D, Baars T, Haude M, Erbel R, et al. Lessons from human coronary aspirate. J Mol Cell Cardiol. 2012; 52: 890-896. doi: 10.1016/j.yjmcc.2011.06.022 PMID: 21762698
7. Heusch G, Kleinbongard P, Skyschally A. Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship. Basic Res Cardiol. 2013; 108: 380. doi: 10.1007/s00395-013-0380-y PMID: 24022372
8. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998; 97: 916-931. PMID: 9521341
9. Pregowski J, Tyczynski P, Mintz GS, Kim SW, Witkowski A, Waksman R, et al. Incidence and clinical correlates of ruptured plaques in saphenous vein grafts. An intravascular ultrasound study. J Am Coll Cardiol. 2005; 45: 1974-1979. PMID: 15963395
10. Shantsila E, Kamphuisen PW, Lip GY. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost. 2010; 8: 2358-2368. doi: 10.1111/j.1538-7836.2010.04007.x PMID: 20695980
11. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010; 107: 1047-1057. doi: 10.1161/CIRCRESAHA.110.226456 PMID: 21030722
12. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011; 109: 593-606. doi: 10.1161/CIRCRESAHA.110.233163 PMID: 21852557
13. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001; 3: 339-345. PMID: 11283606
14. Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol. 1999; 30: 111-142. PMID: 10439058
15. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003; 109: 175-180. PMID: 12757771
16. Vion AC, Ramkhelawon B, Loyer X, Chironi G, Devue C, Loirand G, et al. Shear stress regulates endothelial microparticle release. Circ Res. 2013; 112: 1323-1333. doi: 10.1161/CIRCRESAHA.112. 300818 PMID: 23536307
17. Sluijter JP, Verhage V, Deddens JC, van den AF, Doevendans PA. Microvesicles and exosomes for intracardiac communication. Cardiovasc Res. 2014; 102: 302-311. doi: 10.1093/cvr/cvu022 PMID: 24488559
18. Pfister SL. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension. 2004; 43: 428-433. PMID: 14718367
19. Viera AJ, Mooberry M, Key NS. Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens. 2012; 6: 243-252. doi: 10.1016/j.jash.2012.06.003 PMID: 22789878
20. Leroyer AS, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol. 2007;49: 772-777. PMID: 17306706
21. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 1999; 99: 348-353. PMID: 9918520
22. Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis. 2009; 204: 636-641. doi: 10.1016/j.atherosclerosis.2008.10.039 PMID: 19091315
23. Min PK, Kim JY, Chung KH, Lee BK, Cho M, Lee DL, et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis. 2013; 227: 323-328. doi: 10.1016/j.atherosclerosis.2013.01.032 PMID: 23422831
24. Empana JP, Boulanger CM, Tafflet M, Renard JM, Leroyer AS, Varenne O, et al. Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study. Eur Heart J Acute Cardiovasc Care. 2014;2014[Epub ahead of print]
25. Porto I, Biasucci LM, De Maria GL, Leone AM, Niccoli G, Burzotta F, et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J. 2012; 33: 2928-2938. doi: 10.1093/eurheartj/ehs065 PMID: 22453653
26. Baars T, Konorza T, Kahlert P, Mohlenkamp S, Erbel R, Heusch G, et al. Coronary aspirate TNFalpha reflects saphenous vein bypass graft restenosis risk in diabetic patients. Cardiovasc Diabetol. 2013;12: 12. doi: 10.1186/1475-2840-12-12 PMID: 23305356
27. Kleinbongard P, Boese D, Konorza T, Steinhilber F, Moehlenkamp S, Eggebrecht H, et al. Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosis. Basic Res Cardiol. 2011; 106: 681-689. doi: 10.1007/s00395-011-0177-9 PMID: 21472462
28. Haude M, Caspari G, Baumgart D, Brennecke R, Meyer J, Erbel R. Comparison of myocardial perfusion reserve before and after coronary balloon predilation and after stent implantation in patients with postangioplasty restenosis. Circulation. 1996; 94: 286-297. PMID: 8759068
29. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985; 312: 932-936. PMID: 4038784
30. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001; 37: 1478-1492. PMID: 11300468
31. Boese D, von Birgelen C, Zhou XY, Schmermund A, Philipp S, Sack S, et al. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol. 2008; 103: 587-597. doi: 10.1007/s00395-008-0745-9 PMID: 18787802
32. Leborgne L, Cheneau E, Pichard A, Ajani A, Pakala R, Yazdi H, et al. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J. 2003; 146: 501-506. PMID: 12947370
33. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; 35(37): 2541-2619. doi: 10.1093/eurheartj/ehu278 PMID: 25173339
34. Horn P, Cortese-Krott MM, Amabile N, Hundsdorfer C, Kroncke KD, Kelm M, et al. Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc. 2013; 2: e003764. doi: 10.1161/JAHA.112.003764 PMID: 23525410
35. Erdbrugger U, Rudy CK, Etter E, Dryden KA, Yeager M, Klibanov AL, et al. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry. Cytometry A. 2014; 85:756-770. doi: 10.1002/cyto.a.22494 PMID: 24903900
36. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012; 33(20): 2569-2619. doi: 10.1093/eurheartj/ehs215 PMID: 22922416
37. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003; 145: 962-970. PMID: 12796750
38. Bonello L, Basire A, Sabatier F, Paganelli F, Dignat-George F. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost. 2006; 4: 979-981. PMID: 16689747
39. Craft JA, Masci PP, Roberts MS, Brighton TA, Garrahy P, Cox S, et al. Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients. Blood Coagul Fibrinolysis. 2004; 15: 475-482. PMID: 15311156
40. George FD. Microparticles in vascular diseases. Thromb Res. 2008; 122 Suppl 1: S55-S59. doi: 10.1016/S0049-3848(08)70020-3 PMID: 18691501
41. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost. 2009; 101: 439-451. PMID: 19277403
42. Zhang Y, Liu X, Liu L, Zaske AM, Zhou Z, Fu Y, et al. Contact- and agonist-regulated microvesiculation of human platelets. Thromb Haemost. 2013; 110: 331-339. doi: 10.1160/TH12-11-0853 PMID: 23784603
43. Hamilos M, Muller O, Ntalianis A, Trana C, Bartunek J, Sarno G, et al. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel. J Thromb Thrombolysis. 2011; 32: 64-71. doi: 10.1007/s11239-011-0557-x PMID: 21290254
44. Franca CN, Pinheiro LF, Izar MC, Brunialti MK, Salomao R, Bianco HT, et al. Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J. 2012; 76: 729-736. PMID: 22214900
45. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial funciton in vitro. Am J Physiol Heart Circ Physiol. 2004; 286: H1910-H1915. PMID: 15072974
46. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathiue E, Tedgui E, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001; 104: 2649-2652. PMID: 11723013
47. Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, et al. Microparticles From Human Atherosclerotic Plaques Promote Endothelial ICAM-1-Dependent Monocyte Adhesion and Transendothelial Migration. Circ Res. 2011; 108: 335-343. doi: 10.1161/CIRCRESAHA.110.237420 PMID: 21164106
48. Zwicker JI, Trenor CC, III, Furie BC, Furie B. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol. 2011; 31: 728-733. doi: 10.1161/ATVBAHA.109.200964 PMID: 21252066
49. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res. 2002; 53: 313-325. PMID: 11827681
50. Bonderman D, Teml A, Jakowitsch J, Adlbrecht C, Gyöngyösi M, Sperker W, et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood. 2002; 99: 2794-2800. PMID: 11929768
51. Mahemuti A, Meneveau N, Seronde MF, Schiele F, Descotes-Genon V, Ecarnot F, et al. Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents. J Thromb Thrombolysis. 2009; 28: 333-341. doi: 10.1007/s11239-008-0266-2 PMID: 18766300
52. Tutar E, Ozcan M, Kilickap M, Gulec S, Aras O, Pamir G, et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation. 2003; 108: 1581-1584. PMID: 12975255
53. Mizuno O, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty. Cardiology. 2001; 95: 84-89. PMID: 11423712
54. Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005; 3: 1301-1308. PMID: 15946221
55. Jung F, Spitzer SG, Pindur G. Effect of an ionic compared to a non-ionic X-ray contrast agent on platelets and coagulation during diagnostic cardiac catheterisation. Pathophysiol Haemost Thromb. 2002; 32: 121-126. PMID: 12372925